Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $262,365.00 |
|---|---|
| Enterprise Value | $-4,649,464.00 |
| Earnings per Share | $-98 |
| Beta | -0.65 |
| Outstanding Shares | 1,304,000 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | -0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company ...